The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Diagnosis and treatment of alcohol-associated liver disease: a review

AK Singal, P Mathurin - Jama, 2021 - jamanetwork.com
Importance Alcohol-associated liver disease results in cirrhosis in approximately 10% to
20% of patients. In 2017, more than 2 million people had alcohol-associated cirrhosis in the …

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update

A Berzigotti, E Tsochatzis, J Boursier, L Castera… - Journal of …, 2021 - Elsevier
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review

MT Long, M Noureddin, JK Lim - Gastroenterology, 2022 - Elsevier
Description Nonalcoholic fatty liver disease (NAFLD) is well recognized as a leading
etiology for chronic liver disease, affecting> 25% of the US and global populations. Up to 1 …

[PDF][PDF] Diagnosis and treatment of alcohol‐associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases

DW Crabb, GY Im, G Szabo, JL Mellinger… - Hepatology, 2020 - Wiley Online Library
Alcohol-associated liver disease (ALD) represents a spectrum of liver injury resulting from
alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic …

[HTML][HTML] Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population

I Graupera, M Thiele, M Serra-Burriel… - Clinical …, 2022 - Elsevier
Background & Aims Fibrosis-4 (FIB-4) and the nonalcoholic fatty liver disease fibrosis score
(NFS) are the 2 most popular noninvasive blood-based serum tests proposed for …

AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis

RK Sterling, A Duarte-Rojo, K Patel, SK Asrani… - Hepatology, 2025 - journals.lww.com
Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …

Liver cirrhosis

P Ginès, A Krag, JG Abraldes, E Solà, N Fabrellas… - The Lancet, 2021 - thelancet.com
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …

[HTML][HTML] Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations

G Ferraioli, VWS Wong, L Castera, A Berzigotti… - Ultrasound in medicine …, 2018 - Elsevier
Abstract The World Federation for Ultrasound in Medicine and Biology has produced these
guidelines for the use of elastography techniques in liver diseases. For each available …

EASL Clinical Practice Guidelines: Management of alcohol-related liver disease

M Thursz, A Gual, C Lackner, P Mathurin, C Moreno… - Journal of …, 2018 - Elsevier
The harmful use of alcohol has been estimated to cause approximately 3.3 million deaths
every year, corresponding to nearly 6% of all deaths globally. Therefore, the effective …